Press Release / May 07, 2026
Hovione and IDC Intranasal Drug Delivery Platform Available for Commercial Partnerships
Its lead single-use nasal dry powder device now available for commercial partnerships
Oops! Your browser version is not supported by our website.
Please use these following browsers to view this page:
Its lead single-use nasal dry powder device now available for commercial partnerships
Commitment to partnership and joint innovation for cell and gene therapies